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SUMMARY 
Neutrophil degranulation involves a number of well-orchestrated structural and 
biochemical events. We have investigated the mechanism of intracellular 
signalling involved in neutrophil degranulation that was mediated by the high 
affinity leukotriene (LT)B4 receptor, BLT1. The model systems used were 
consisted of Peripheral blood neutrophils as well as promyeloid PLB-985 cells, 
stably transfected with human BLT1 cDNA (PLB-BLT) or a substitution mutant 
(2L(304-305)/A) of the distal dileucine motif in helix VIII of BLT1, and 
differentiated into a neutrophil-like phenotype. The degranulation of these cells 
was measured in the presence and absence of factors that would affect the 
signaling pathway. The results show that Degranulation responses to LTB4 were 
similar for differentiated PLB-BLT1 and neutrophils. However, the degranulation 
response of cells bearing the dileucine mutation in helix VIII of BLT1 was 
significantly reduced in response to LTB4. Pretreatment of differentiated PLB-
BLT1 cells and neutrophils with Y-27632, a pharmacological inhibitor of pi 60-
ROCK, the down-stream effector of the small GTPase RhoA, abrogated their 
degranulation in response to LTB4. The degranulation defect observed with the 
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dileucine mutation was corrected by transient transfection of the cells bearing the 
mutation with a constitutively active form of RhoA. Taken together, our results 
suggest an essential role for the distal dileucine motif in helix VIII of BLT1 
involving RhoA which allows normal neutrophil degranulation in response to 
LTB4. 
Key words: Neutrophil, BLT1, helix VIII, distal dileucine motif, RhoA signaling, 
degranulation. 
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Introduction 
1.0 Human Neutrophils 
Neutrophils are key cellular elements of the innate immune system, which provide 
protection from invading bacteria. When normal regulatory mechanisms fail, the 
neutrophil is also responsible for immunologically induced tissue injury (Faist and Kim 
1998). Following activation by bacterial by-products or other immune stimuli such as 
lipopolysaccharides, glycolipids, and methylated DNA, neutrophils execute several 
specialized functions that include chemotaxis, phagocytosis and the generation of reactive 
oxygen metabolites. All of these processes are required for the elimination of invading 
micro-organisms or cellular debris. 
Neutrophils are highly mobile, short-lived white blood cells that are densely packed with 
secretory granules. They emigrate from the bone marrow into the blood and infiltrate 
tissues in response to injury or infection. In healthy individuals, peripheral blood 
neutrophils make up the majority of white blood cells (40-80%). 
The lungs have the largest marginated pool of neutrophils in the body; they fulfill an 
important role in maintaining alveolar sterility. As a major effector cell in innate 
immunity neutrophils act as a "double-edged sword". If neutrophils are absent, for 
example in congenital neutropenia, or the more common "cyclic neutropenia" 
opportunistic infections result from overgrowth of normally resident skin and gut bacteria 
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and fungi at sites of injury, or exposed mucosal tissues. At the other extreme, 
accumulation and over activation of neutrophils can be fatal in disorders such as in septic 
shock or acute respiratory distress. The tissue-damaging effects of neutrophils are 
completely dependent on their degranulation. 
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2.0 Leukotriene B4 (LTB4) 
2.1 Arachidonic acid 
Arachidonic acid plays a central role in a biological control system where such 
oxygenated derivatives as prostaglandins, thromboxanes, and leukotrienes are mediators. 
The leukotrienes are formed by transformation of arachidonic acid into an unstable 
epoxide intermediate, leukotriene A4, which can be converted enzymatically by hydration 
to leukotriene B4, and by addition of glutathione to leukotriene C4. Leukotriene C4 is 
metabolized to leukotrienes D4 and E4 by successive elimination of a gamma-glutamyl 
residue and glycine. The Slow-reacting substance found during anaphylaxis consists of 
leukotrienes C4, D4, and E4. The cysteinyl-containing leukotrienes are potent 
bronchoconstrictors which increase vascular permeability in postcapillary venules, and 
stimulate mucus secretion. Leukotriene B4 causes adhesion and chemotactic movement 
of leukocytes and stimulates aggregation, enzyme release, and generation of superoxide 
in neutrophils. Leukotrienes C4, D4, and E4, which are released from the lung tissue of 
asthmatic subjects exposed to specific allergens, seem to play a pathophysiological role in 
immediate hypersensitivity reactions. These leukotrienes, as well as leukotriene B4, have 
pro-inflammatory effects. 
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2.2 Leukotriene B4 (LTB4) 
LTB4 was initially discovered by Borgeat and Samuelsson,(Borgeat and Samuelsson 
1979) and found to be a potent neutrophil chemoattractant by Ford-Hutchinson et al. 
(Ford-Hutchinson, Bray et al. 1980). A high-affinity binding site for LTB4 on human 
neutrophils was initially detected by Goldman and Goetzl in 1982 with a K& of 0.39nM 
(Goldman and Goetzl 1984),others detected this binding site with K<j of 0.46nM (Lin, 
Ruppel et al. 1984), and 1.5nM (Bomalaski and Mong 1987). Leukotriene B4 (LTB4) is 
an extremely potent lipid inflammatory mediator derived from membrane phospholipids 
by the sequential actions of cytosolic phospholipase A2, 5-lipoxygenase (5-LO) and LTA4 
hydrolase. 
The major activities of LTB4 include the recruitment and activation of leukocytes, 
suggesting that it has considerable functional overlap with the chemokine family of 
chemoattractant peptides, which also direct the recruitment of leukocytes. Though 
structurally completely different, the lipid LTB4 and the peptide chemokines mediate 
their function through the same class of receptors, the G protein-coupled seven 
transmembrane domain receptor (GPCR) superfamily. 
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Two GPCRs for LTB4 have been identified, BLT1 and BLT2. By mediating the activities 
of LTB4, these receptors participate both in the recruitment and activation of leukocytes 
as part of host immune responses to invading pathogens, as well as in the pathogenesis of 
inflammatory diseases in which LTB4 has been implicated. 
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3.0 Leukotriene B4 receptors BLT1 and BLT2 
3.1 BLT1 
Molecular identification of a receptor for LTB4 eluded investigators for many years, 
however, human high-affinity LTB4 receptor was finally cloned by Yokomizo et al. in 
1997 from retinoic acid-differentiated HL-60 cells using a subtraction strategy 
(Yokomizo, Izumi et al. 1997), and the mouse ortholog by Huang et al. (Huang, Garcia-
Zepeda et al. 1998). This receptor was initially named BLTR, and subsequently renamed 
BLT1 when a second LTB4 receptor was identified. Membrane fractions of COS-7 cells 
transfected with the BLT1 cDNA demonstrated LTB4 binding with a Kd comparable to 
that observed in retinoic acid-differentiated HL-60 cells, and CHO cells stably transfected 
with the BLT1 cDNA demonstrated LTB4-induced increases in intracellular calcium and 
chemotactic responses, indicating that this cDNA encoded the high-affinity LTB4 
receptor (Yokomizo, Izumi et al. 1997). 
Interestingly, this sequence had been previously cloned using degenerate PCR strategies 
by two independent groups as an orphan receptor gene that appeared to encode a member 
of the G protein-coupled seven transmembrane domain receptor (GPCR) superfamily. At 
that time, the receptor was called R2 by Raport et al. (Raport, Schweickart et al. 1996) 
and chemoattractant receptor-like 1 (CMKRL1) by Owman et al. (Owman, Nilsson et al. 
1996). 
7 
The mouse ortholog of BLT1 was independently cloned by Huang et al. In 1998, by 
performing degenerate PCR with primers directed to well-conserved transmembrane 
domains of chemoattractant GPCRs, using cDNA isolated from murine eosinophils 
(Huang, Garcia-Zepeda et al. 1998). 
Martin et al. identified the identical murine sequence by screening a mouse genomic 
library with a fragment of the human cDNA identified previously as encoding the P2Y7 
receptor (Martin, Ronde et al. 1999). 
Human BLT1 gene was localized to chromosome 14 (Raport, Schweickart et al. 1996; 
Owman, Nilsson et al. 1996; Akbar, Dasari et al. 1996). Kyte-Doolittle hydrophobicity 
analysis of the amino acid sequences of human (Owman, Nilsson et al. 1996; Raport, 
Schweickart et al. 1996) and mouse (Huang, Garcia-Zepeda et al. 1998) BLT1 showed 
the presence of seven hydrophobic transmembrane domains common to GPCRs. The 
amino acid sequences also contain other motifs characteristic of this family of receptors 
(Huang, Garcia-Zepeda et al. 1998; Owman, Nilsson et al. 1996), including (a) conserved 
proline residues in several of the transmembrane domains, which are thought to induce 
flexibility in the helix formations; (b) conserved cysteine residues in two of the 
extracellular loops for intra-molecular chain disulfide bonding; (c) a serine and threonine-
rich C-terminal intra-cytoplasmic segment, which in other GPCRs are sites of 
phosphorylation involved with receptor desensitization and internalization; and (d) 
consensus sequences for N-
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linked glycosylation near the N-terminus and in one of the extracellular loops (Murphy 
1994). 
Mouse BLT1 has been demonstrated to be N-linked glycosylated, as in-vitro translation 
of the cDNA in the presence of dog pancreatic microsomes revealed an upward shift in 
mobility of the protein product on SDS-PAGE of -,4kD compared with the protein 
product translated in the absence of microsomes (Huang, Garcia-Zepeda et al. 1998). The 
highly conserved DRYLAIV motif at the end of the third transmembrane region of the 
GPCR family of receptors is present as DRSLAV in both human and mouse BLT1 
(Yokomizo, Izumi et al. 1997; Huang, Garcia-Zepeda et al. 1998). 
Human BLT1 is 352 amino acid residues in length, and mouse BLT1 is 351 amino acids, 
similar to the lengths of other chemoattractant receptors (Murphy 1994). The primary 
structures of human and mouse BLT1 are 78% identical at the amino acid level. 
Interestingly, the three intra-cytoplasmic loops are identical across these species. In 
contrast, these sequences are not conserved across the subfamily of chemoattractant 
receptors, suggesting that human and mouse BLT1 may be coupled to a unique, well-
conserved, signaling pathway among the chemoattractant receptors (Huang, Garcia-
Zepeda et al. 1998). 
Leukocyte BLT1 expression is up-regulated in inflammation. Mouse BLT1 transcription, 
which is not detectable in resting peritoneal cells, is dramatically increased in both 
activated macrophages and neutrophils elicited into the peritoneum of mice by sodium 
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casein injection (Huang, Garcia-Zepeda et al. 1998). IFNy and glucocorticoids have also 
been shown to induce BLT1 expression. Mouse BLT1 transcription is induced in the 
RAW 264.7 macrophage cell line by IFNy (Huang, Garcia-Zepeda et al. 1998), and 
human BLT1 transcription is induced in peripheral blood neutrophils by dexamethasone 
(Stankova, Turcotte et al. 2002). 
Table 1: Regulators of BLT1 expression 
Regulators of BLT1 expression 
• Increased by • Decreased by 
LTB4 IFN-y, 
IL-10, LPS, 
Dexamethasone TNFa 
IL-2 
IL-15 
Petterson A., et al, 2005, Stankova J. et al, 2002 
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3.2 BLT2 
Binding studies of LTB4 suggested that in addition to the presence of a high-affinity 
receptor, a second, low-affinity LTB4 receptor was also present on human neutrophils 
(Goldman and Goetzl 1984; Lin, Ruppel et al. 1984) with a Kd of 61nM (Goldman and 
Goetzl 1984). BLT2, a second seven transmembrane spanning G protein-coupled LTB4 
receptor, was identified by Yokomizo et al. (Yokomizo, Kato et al. 2000). 
Membrane fractions of HEK 293 cells transfected with the cloned human BLT2 
demonstrated specific and saturable LTB4 binding with a K& of 22.7nM, approximately 
20-fold higher than human BLT1 transfectants. CHO cells stably transfected with human 
BLT2 also demonstrated LTB4-induced increases in intracellular calcium and 
chemotactic responses, indicating that this sequence encoded an LTB4 receptor. This was 
confirmed when human BLT2 was independently cloned to be an LTB4 receptor by three 
additional groups (Tryselius, Nilsson et al. 2000; Kamohara, Takasaki et al. 2000; Wang, 
Gustafson et al. 2000). 
The two LTB4 receptor genes form a cluster in both the human (Nilsson, Tryselius et al. 
2000; Yokomizo, Kato et al. 2000) and mouse (Yokomizo, Kato et al. 2000) genomes. 
The human BLT2 gene being located approximately 3 kb 5' of the human BLT1 gene, 
and overlaps the 5' untranslated region of one of the 4' identified splice variants of BLT1 
(Nilsson, Tryselius et al. 2000). Both genes are transcribed in the same direction. The 
mouse BLT2 gene similarly is located approximately 4 kb 5' of the BLT1 coding 
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sequence (Yokomizo, Kato et al. 2000). The identity between human BLT1 and BLT 2 at 
the amino acid level, of 45.2%, is lower than that between CXCR1 and CXCR2 (77%) or 
between FPR1 and FPRL1 (69%) or FPRL2 (58%), suggesting that the duplication event 
that generated the two LTB4 receptors may have occurred earlier than the events that 
generated these other receptor clusters (Yokomizo, Kato et al. 2000). 
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3.3 BLT1 and BLT2 signaling 
BLT1 and BLT2 can be distinguished pharmacologically. Multiple LTB4 receptor 
antagonists have been developed, including CP-105,696 (Showell, Pettipher et al. 1995), 
CP-195,543 (Showell, Conklyn et al. 1998), U-75302 (Lawson, Wishka et al. 1989), 
LY255283 (Herron, Goodson et al. 1992), ZK 158252 and ONO-4057 (Kishikawa, 
Tateishi et al. 1992; Yokomizo, Kato et al. 2000). Some of these agents selectively 
antagonize BLT1 or BLT2, whereas others antagonize both receptors. CP-105,696 and U-
75302 compete with LTB4 binding in a dose-dependent manner to membrane fractions of 
CHO cells expressing human BLT1 but not human BLT2, LY 255283 competes with 
LTB4 binding to human BLT2 but not human BLT1, and ZK 158252, CP-195,543, and 
ONO 4057 compete with LTB4 binding to both receptors (Yokomizo, Kato et al. 2000; 
Yokomizo, Kato et al. 2001). 
There are two principal signal transduction pathways involving the G-protein coupled 
receptors: the cAMP signal pathway and the Phosphatidylinositol signal pathway. When 
a ligand binds to the GPCR it causes a conformational change in the GPCR which allows 
it to act as a guanine nucleotide exchange factor (GEF). The GPCR can then activate an 
associated G-protein by exchanging its bound GDP for a GTP. The G-protein's a subunit, 
together with the bound GTP, can then dissociate from the P and y subunits to further 
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affect intracellular signaling proteins or target functional proteins directly depending on 
the a subunit type (Gas ,Gai, Gaq/n, Gai2/i3). 
Table2: Characteristics of BLT1 and BLT2. 
BLT1 BLT2 
Gene location chromosome 1 4q 
11.2-ql2 
Amino acids 
352 amino acids 358 amino acids 
Identity between 
human and 
mouse 78.6% 92.7% 
Agonists LTB4 
12 epi-LTB4 
LTB4 
12 epi-LTB4 
12(s)-HTETE 
12(s)HPETE 
12(R)HTETE 
20-hydroxy LTB4 
Pharmacologic 
inhibitors 
CP105696 
CP195543 
ZK158252 
U75302 
0N04Q57 
CP195543 
ZK158252 
ON04057 
LY2442843 
Homology between BLTland BLT2 is 45.2% 
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Some differences in G protein-coupling have been observed between the two receptors. 
BLT1 and BLT2 receptors appear to use different G proteins in mediating different 
cellular events, and receptor G protein coupling may differ in different cell types. LTB4-
induced chemotaxis of CHO cells stably transfected with either human BLT1 or human 
BLT2 is completely abolished by Bordetella pertussis toxin (PTX), suggesting that 
chemotatic responses directed by both receptors involve Gctj/o subunit signaling. In 
contrast, increases in intracellular calcium induced by LTB4 in CHO-human BLT1 and 
CHO-human BLT2 transfectants are only partially hlocked by PTX, indicating that 
calcium responses directed by the two receptors are mediated by both PTX-sensitive and 
PTX-insensitive G proteins in CHO cells (Yokomizo, Izumi et al. 1997; Yokomizo, Kato 
et al. 2000). 
Experiments co-transfecting BLT1 with different Ga subunits into COS-7 cells indicate 
that BLT1 can couple to Gai6, a PTX-insensitive a subunit of the Gq class of G proteins 
(Gaudreau, Le Gouill et al. 1998). As opposed to the results with CHO transfectants, 
LTB4-induced increase in intracellular calcium in human neutrophils was largely PTX-
sensitive (Powell, MacLeod et al. 1996), suggesting that the LTB4 receptors couple to 
different types of G proteins in different cell types. Both LTB4 receptors also mediate 
inhibition of forskolin-induced adenylyl cyclase activity, but do so using different G 
proteins. Whereas inhibition of forskolin-induced adenylyl cyclase activity by LTB4 was 
reduced approximately 80% by PTX in CHO-human BLT1 transfectants, PTX had a 
negligible effect on LTB4-induced inhibition of forskolin-induced adenylyl cyclase 
activity in CHO-human BLT2 transfectants (Yokomizo, Kato et al. 2000). 
3.4 Helix VIII of BLT1 receptor 
BLT1 belongs to the rhodopsin subfamily of GPCRs analysis of the crystal structure of 
rhodopsin confirmed the presence of 7 transmembrane (TM) helices and revealed the 
existence of an 8th helix (helix VIII) that projects at a right angle from the C terminus of 
TM7 (Palczewski, Kumasaka et al. 2000) . This short helix of rhodopsin is anchored by a 
palmitoyl group to the cytoplasmic leaflet of the cell membrane, and a hypothetical model 
has predicted that helix VIII interacts with the N-terminal helix of the Ga and Gy subunits 
(Lu, Saldanha et al. 2002). BLT1 was demonstrated to contain the helix VIII in its 
intracellular C terminus (Okuno, Ago et al. 2003; Gaudreau, Beaulieu et al. 2004). 
BLT1 mutants with a truncated or substituted helix VIII showed much higher LTB4 
binding than wild-type (WT) receptor in HEK293 and CHO cells, albeit with comparable 
expression on the cell surface (Okuno, Ago et al. 2003). Similar to the WT receptor, in 
mutant receptors LTB4 promoted binding of GTPyS. However unlike WT-BLT1, the 
addition of GTPyS did not inhibit LTB4 binding to the mutant receptors. 
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The mutant receptors maintained a high affinity for LTB4, even in the presence of an 
excess amount of GTPyS. They also showed more prolonged intracellular signaling (e.g. 
calcium mobilization and metabolic activation) after LTB4 treatment. The BLT1 model 
predicts a helix VIII extending from TM7, similar to the one observed in rhodopsin. The 
BLT1 model suggests that a pair of aromatic residues (Tyr-285 and Phe-300), which are 
positioned similarly to the conserved Tyr-306 and Phe-313 pair in rhodopsin, may 
stabilize the inactive form of the receptor by holding TM7 and helix VIII at almost a right 
angle to each other. 
Gaudreau et al. (Gaudreau, Le Gouill et al. 2002) proposed that Thr-308 is involved in 
GRK6-mediated desensitization of BLT1 signaling. This suggested that Phosphorylation 
at that site may also play a role in inactivation of BLT1. 
In addition Gaudreau et al. (Gaudreau, Beaulieu et al. 2004) also proposed that helix VIII 
is involved in a hydrophobic core containing other hydrophobic residues in helix 1 and 
disruption of this hydrophobic core may facilitate the irreversible activation of BLT1. 
Therefore Cell surface expression levels of helix VIII mutants of BLT2 are considerably 
reduced. The helix VIII of BLT2 might also be important for receptor sorting, Several 
studies suggest that helix VIII of BLT1 may play an important role in the inactivation of 
BLT1 after G-protein activation, possibly by sensing Gft subunits as being GTP-bound. 
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Using reconstitution of a budded baculovirus expression system, Masuda et al. (Masuda, 
Itoh et al. 2003) showed that trimeric G-proteins were required for maintenance of the 
high affinity state of BLT1. The binding affinity of GPCR is thus critically dependent on 
the status of G-proteins, which suggest that further studies will reveal an important role of 
helix VIII in downstream signaling. 
18 
4.0 Rho GTPases 
Rho GTPases are members of the Ras super family of monomeric 20-30 kDa GTP-
binding proteins. Ten different mammalian Rho GTPases, some with multiple iso forms, 
have been identified to date (Jones, Ridley et al. 2000). The most extensively 
characterized members are RhoA, Racl and 2 and Cdc42. Each of these GTPases act as a 
molecular switch, cycling between an active GTP-bound, and an inactive GDP-bound, 
state. In the GTP-bound form they are able to interact with effector or target molecules to 
initiate a downstream response, while an intrinsic GTPase activity returns the proteins to 
the GDP-bound state, to complete the cycle and terminate signal transduction. 
The major function of Rho GTPases is to regulate the assembly and organization of the 
actin cytoskeleton (Hall 1998). The effects of 3 members of the Rho family RhoA, Rac 
and Cdc42 were initially described using quiescent Swiss3T3 fibroblasts, a cell line in 
which serum starvation creates a very low background of organized F-actin structures. 
Addition of lysophosphatidic acid induce the formation of contractile actin-myosin stress 
fibres and associated focal adhesions, and which was blocked by C3 transferase (Ridley 
and Hall 1992). 
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The dominant-negative Rac specifically inhibits the response (Ridley, Paterson et al. 
1992).to Growth factors, such as platelet-derived growth factor, insulin or epidermal 
growth factor (EGF) which induce the formation of actin-rich lamellipodia and 
membrane ruffles associated with focal contacts. 
Bradykinin a nine amino acid peptide induces the formation of peripheral microspikes or 
filopodia, which are also associated with focal contacts, and this can be inhibited by 
expression of dominant-negative Cdc42 (Kozma, Ahmed et al. 1995). 
Rho GTPases have also been found to play a role in a variety of cellular processes that 
are dependent on the actin cytoskeleton, such as cytokinesis (Mabuchi, Hamaguchi et al. 
1993; Prokopenko, Saint et al. 2000) phagocytosis (Cox, Chang et al. 1997; Caron and 
Hall 1998), pinocytosis (Ridley, Paterson et al. 1992), cell migration (Nobes and Hall 
1999; Allen, Zicha et al. 1998), morphogenesis (Settleman 1999) and axon guidance 
(Luo, Jan et al. 1997). 
In addition to their effect on the actin cytoskeleton, they also regulate a variety of other 
biochemical pathways, including serum response factor (SRF) and nuclear factor kB (NF-
kB) transcription factors (Hill, Wynne et al. 1995; Perona, Montaner et al. 1997), the c-
jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase pathways (Coso, 
Chiariello et al. 1995; Minden, Lin et al. 1995), the phagocytic NADPH oxidase complex 
(Abo, Pick et al. 1991), Gi cell-cycle progression (Olson, Ashworth et al. 1995), the 
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assembly of cadherin-containing cell-cell contacts (Braga 1999), (Kaibuchi, Kuroda et al. 
1999), secretion in mast cells (Norman, Price et al. 1996), cell polarity (Johnson 1999) 
and cell transformation (Van Aelst and D'Souza-Schorey 1997). 
Therefore, although Rho GTPases are best characterized for their effects on the actin 
cytoskeleton, there is now much interest in their ability to affect cell proliferation and 
gene transcription and degranulation of neutrophils. Thus studies using inhibition always 
show some effect and are hard to analyse 
2 1 
5.0 Neutrophils Granules and Degranulation 
5.1 Granule Population in Neutrophils. 
Neutrophils contain at least four different types of granules identified by subcellular 
fractionation and transmission electron microscopy. These are: primary granules, also 
known as azurophilic granules, secondary granules, also known as specific granules, 
tertiary granules, and secretory vesicles. The primary granules are the main storage site of 
the most toxic neutrophil-derived mediators, including elastase, myeloperoxidase, 
cathepsins, and defensins. The secondary and tertiary granules contain lactoferrin and 
matrix metalloprotease-9 (MMP-9, also known as gelatinase B), respectively (Borregaard 
and Cowland 1997). 
The secretory vesicles in human neutrophils contain human serum albumin, suggesting 
that they derive from endocytosis. The secondary and tertiary granules have similar 
contents but can be discriminated by their different intrinsic buoyant densities when 
centrifuged on gradient media (Kjeldsen, Sengelov et al. 1994). All of these granule types 
are retained in the cell cytoplasm and are not released until receptors in the plasma 
membrane or phagosomal membrane signal to the cytoplasm to activate their movement 
for secretion of their contents by exocytosis. Thus, the receptor-linked secretory pathway 
is an important control mechanism, as the neutrophil is highly enriched in tissue-
destructive proteases and other enzymes. 
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5.2 Degranulation 
Degranulation is defined as the secretion by receptor-mediated exocytosis of granule-
derived substances. Upon receptor-mediated stimulation of neutrophils, granules are 
mobilized triggering their docking and content secretion which can occur intracellularly 
with microbe-laden phagosomes, or extracellularly at the plasma membrane. Upon 
exocytosis of granules, neutrophils release a diverse array of antimicrobial proteins and 
enzymes, many of which also possess tissue-damaging properties. At the same time, 
neutrophils release reactive oxygen species by respiratory burst, to aid in pathogen 
clearance, in addition to cytokines, which recruit additional leukocytes to the region of 
infection or inflammation. 
A recent study by Brinkmann et a/ (Brinkmann, Reichard et al. 2004) described a novel 
mechanism causing elimination of microbial pathogens by neutrophils. Upon activation 
by ligands such as interleukin-8 (IL-8), lipopolysaccharide, and interferon-y with 
complement 5a (Martinelli, Urosevic et al. 2004), neutrophils generated a web of 
extracellular fibres known as "neutrophil extracellular traps" (NETs), composed of DNA, 
histones, and antimicrobial granule proteins, which were highly effective at trapping and 
killing invasive microbes. The authors proposed that NETs amplified the effectiveness of 
antimicrobial components by concentrating them in a fibrous, net-like structure and 
reducing their exposure to host tissues. 
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Even though this report did not suggest the molecular mechanisms responsible for NET 
formation and its association with granular protein, it opened a new horizon in the field of 
neutrophil biology in relation to mediator release and bactericidal activity. Moreover, it 
has been recently suggested that NET formation may be an important mechanism for 
control of sepsis (Clark, Ma et al. 2007). 
In many inflammatory disorders, such as acute lung injury, ischemia, reperfusion injury, 
severe asphyxic asthma, rheumatoid arthritis, and septic shock, excessive neutrophil 
degranulation is a common feature. Recent findings have identified a number of 
important signaling pathways in neutrophils that may be essential for neutrophil 
exocytosis. 
5.3 Degranulation mechanism in neutrophils 
Receptor stimulation of neutrophils by a secretagogue triggers granule translocation to 
the phagosomal or plasma membrane, where they dock and fuse, releasing their contents. 
The release of granule-derived mediators from neutrophils occurs by a tightly controlled 
receptor-coupled mechanism termed "regulated exocytosis". Exocytosis is postulated to 
take place in four discrete steps (Toonen and Verhage 2003). 
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The first step of exocytosis is granule recruitment from the cytoplasm and translocation 
to the target membrane, which is dependent on actin cytoskeleton remodeling and 
microtubule assembly (Burgoyne and Morgan 2003). This is followed by the second step 
of granule tethering and docking, leading to contact of the outer surface of the granule 
lipid bilayer membrane with the inner surface of the target membrane. Granule priming 
then follows as the third step to make granules fusion-competent and ensure that they 
fuse rapidly, to form a reversible pore structure between the granule and the target 
membrane. 
The fourth and final step, granule fusion, occurs by rapid expansion of the fusion pore, 
leading to complete fusion of the granule membrane with the target membrane and 
expulsion of the granular contents to the outside of the cell. 
This increases the total surface area of the cell, and exposes the interior surface of the 
granule membrane to the exterior. Tethering and docking steps require the sequential 
action of Rab and SNARE proteins (Stow, Manderson et al. 2006); whether these factors 
are also needed for subsequent steps of fusion remains to be determined. 
Translocation and exocytosis of granules from neutrophils require, as a minimum, 
increases in intracellular Ca2+ and guanosine triphosphate (GTP) as well as hydrolysis of 
adenosine triphosphate (ATP) (Nusse and Lindau 1988; Theander, Lew et al. 2002). 
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Not surprisingly, there are numerous target molecules for these effectors, including Ca2+-
binding proteins such as annexins and calmodulin, and GTP-binding proteins such as 
heterotrimeric and small monomeric G proteins. The role of ATP in exocytosis as well as 
kinases, is to act as an energy source for SNARE complex reorganization and as a 
phosphate donor for phosphorylation of downstream effector molecules. 
5.4 Actin cytoskeletal dynamics in exocytosis 
Actin remodeling is clearly a prime downstream target of activated effector molecules 
during receptor-mediated exocytosis. The actin cytoskeleton forms a mesh around the 
periphery in many different kinds of secretory cells (i.e., neutrophils, mast cells, neurons 
and endocrine cells). This may act as a shield against aberrant granule docking and fusion 
at the plasma membrane. So in this case the actin cytoskeletal mesh would have to be 
disassembled during exocytosis (Norman, Price et al. 1994; Muallem, Kwiatkowska et al. 
1995; Takao-Rikitsu, Mochida et al. 2004). 
However, some studies suggest that F-actin has normally a very diffuse distribution in 
resting neutrophils, and only assembles into a cortical ring upon stimulation by f-Met-
Leu-Phe (Downey, Elson et al. 1991; Filippi, Harris et al. 2004). In the latter studies, live 
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neutrophils were first adhered to poly-L-lysine-coated glass slides (which itself leads to 
activation), before stimulation with f-Met-Leu-Phe for a period of time prior to fixation. 
Therefore, this procedure may lead to F-actin remodeling prior to stimulation. 
Several other studies report that actin remodelling is needed to direct neutrophil 
migratory responses (Affolter and Weijer 2005). Directed neutrophil movements, or 
chemotaxis towards sites of infection, are driven by polarized F-actin formation, with the 
leading edge of cells showing enhanced levels of actin polymerization. Interestingly, 
neutrophils produce a polarized response even when subjected to uniform concentrations 
of chemoattractants, and maintain this polarity via continued production of activated 
effector molecules such as 3-phosphoinositol lipids in the cell membrane (Zigmond, 
Levitsky et al. 1981; Xu, Wang et al. 2003). A recent comprehensive study of neutrophil 
granule proteins revealed that actin associates with all granule subsets, which suggests 
that actin may play an active role in regulating neutrophil exocytosis (Jog, Rane et al. 
2007). 
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5.5 Ca2+ signaling in exocytosis 
Increases in intracellular Ca2+ alone are sufficient to induce the release of granules from 
neutrophils, particularly if the concentration of Ca2+ is elevated to sufficiently high levels 
by the use of Ca2+ ionophores such as A23187 or ionomycin. A hierarchy of granule 
release exists in response to elevating concentrations of Ca2+ (Pinxteren, O'Sullivan et al. 
2000; Sengelov, Kjeldsen et al. 1993). The order of release is secretory vesicles > tertiary 
granules > secondary granules > primary granules (Sengelov, Kjeldsen et al. 1993; 
Bentwood and Henson 1980). 
The release of each type of granule appears to be differentially regulated by unique 
intracellular signaling pathways. Activation of many neutrophil receptors causes elevated 
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Ca levels, including the seven transmembrane-spanning G protein-coupled receptors 
such as the formyl peptide receptor (that binds the bacterial tripeptide, f-Met-Leu-Phe) 
and chemokine receptors (such as the interleukin-8 receptor, CXCR1) (Andersson, 
Dahlgren et al. 1986; Itagaki, Kannan et al. 2002). Although Ca2+ is a crucial second 
messenger in the activation of exocytosis, the specific target molecules for Ca2+ in 
neutrophil degranulation have not yet been identified. Several candidates have been 
suggested, notably annexins, protein kinase C, and calmodulin, all of which bind Ca2+ to 
modulate their activities (Brown, Reed et al. 1991; Sjolin, Stendahl et al. 1994; 
Steadman, Petersen et al. 1996; Donnelly and Moss 1997; Haribabu, Richardson et al. 
2000). Neutrophils have been shown to require these Ca2+-binding proteins for 
granuletranslocation and exocytosis. 
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5.6 Phospholipid signaling in degranulation 
Numerous studies have indicated a role for phospholipids, particularly 
polyphosphoinositides, in regulation of neutrophil degranulation. Polyphosphoinositide 
production, such as phosphatidylinositol 4,5-bisphosphate (PIP2), induced by the 
activation of the hematopoietic cell-specific isoform phosphatidylinositol 3-kinase-g 
(PI3Kg ) has been shown to be required for granule exocytosis in permeabilized 
neutrophilic-like cells, HL-60 cells (Fensome, Cunningham et al. 1996). 
Intracellular sites of PIP2 formation in neutrophils are not known, but are likely to occur 
both at the plasma and granule membranes. Regions of PIP2 enrichment in the membrane 
form essential binding sites for many intracellular signaling molecules, particularly those 
that contain pleckstrin homology domains, such as Rho guanine exchange factors 
including Vav, which signal downstream to Rho guanosine triphosphatases (GTPases) 
(Kim, Marchal et al. 2003; Gakidis, Cullere et al. 2004; Fumagalli, Zhang et al. 2007) . 
Phosphatidylinositol transfer protein (PI-TP) has been shown to be essential for the 
transport of phosphatidylinositol to cellular membranes as a substrate for PI3K activity to 
generate PIP2, and is also capable of restoring exocytotic responses in HL-60 cells 
(Fensome, Cunningham et al. 1996). 
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In addition, a role for phospholipase D has been indicated in neutrophil degranulation, 
particularly for primary and secondary granule release, as its product, phosphatidic acid, 
induces the release of these granules (Kaldi, Szeberenyi et al. 2002). Phosphatidic acid 
and its lipid derivative, lysophosphatidic acid, may act as second messengers for 
downstream reactions, but they clearly aid fusion through the generation of membrane 
curvature (Kooijman, Chupin et al. 2003). Thus, membrane lipid remodelling is also an 
essential component of degranulation in neutrophils. 
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5.7 Role for src family kinases in neutrophil degranulation 
Protein phosphorylation is a critical event in neutrophil activation leading from receptor 
stimulation to exocytosis. Phosphorylation is carried out by kinases which are themselves 
frequently activated by phosphorylation of molecules situated upstream. This specifically 
involves the attachment of a phosphate molecule, donated by intracellular ATP, to a key 
site in the effector molecule, leading to conformational changes that cause activation. 
Receptor stimulation through the formyl peptide receptor by f-Met-Leu-Phe leads to 
phosphorylation of a wide range of kinases which then activate their respective effector 
pathways. 
Protein kinases can be discriminated based on their affinity for different amino acid 
residues in effector molecules. Thus, serine/threonine kinases and tyrosine kinases have 
been characterized as two distinct types of kinases involved in receptor signaling. 
Tyrosine kinases are further differentiated for their intrinsic association with the 
intracellular domain of receptors (receptor tyrosine kinases) or as cytosolic enzymes 
(nonreceptor tyrosine kinases). The src family of nonreceptor tyrosine kinases have been 
implicated in the control of exocytosis of granule products from neutrophils. 
Three src family members, Hck, Fgr, and Lyn, are expressed in neutrophils and activated 
by f-Met-Leu-Phe receptor stimulation. Hck translocates to the myeloperoxidase-positive 
primary granule population following cell activation (Mohn, Le Cabec et al. 1995; 
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Kooijman, Chupin et al. 2003; Gutkind and Robbins 1989) , while Fgr becomes 
associated with the lactoferrin-containing secondary granules during exocytosis (Mocsai, 
Jakus et al. 2000). The selective recruitment of src kinases indicates that different 
signaling pathways exist in neutrophils to induce the release of each granule population. 
Treatment of human neutrophils with the src family inhibitor PP1 has led to inhibition of 
the release of primary granules, secondary granules, and secretory vesicles in response to 
f-Met-Leu-Phe (Barlic, Andrews et al. 2000). Neutrophils isolated from hck,~fgr~'~lyri/~ 
triple knockout mice also showed a deficiency in secondary granule release of lactoferrin, 
although it was not possible to determine primary granule release of glucuronidase from 
murine cells(Barlic, Andrews et al. 2000) . 
Hck and Fgr were recently shown to regulate the activation of the Rho GEF and Vavl 
that signals through the Rho GTPase and Rac inducing actin polymerization and 
superoxide release (Fumagalli, Zhang et al. 2007). The deficiency in secondary granule 
release in triple knockout neutrophils correlated with reduced p38 mitogen-activated 
protein (MAP) kinase activity, suggesting that src kinases act upstream of p38 MAP 
kinase. Indeed, treatment of human neutrophils with the p38 MAP kinase inhibitor, 
SB203580, led to reduced primary and secondary granule exocytosis in response to fMLP 
(Barlic, Andrews et al. 2000). 
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However, another MAP kinase inhibitor, PD98059, which blocks ERK1/2 activity, did 
not affect release of primary and secondary granules or secretory vesicles (Barlic, 
Andrews et al. 2000). These findings indicate that src kinases, Hck, Fgr, and Lyn, along 
with p38 MAP kinase, but not ERK1/2, play a role in regulating the release of granules. 
Gaudreault et al. (Gaudreault, Thompson et al. 2005) demonstrated that there is partial 
involvement of src family kinase potentially Yes kinase in LTB4 mediated neutrophil 
degranulation and that receptor endocytosis is crucial for Yes kinase activation. 
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5.8 Arrestin function in regulating exocytosis 
A group of scaffolding proteins known as arrestins 2 and 3 have also been shown to be 
required for activating signaling pathways leading to exocytosis of primary and 
secondary granules in neutrophils (Ferguson, Downey et al. 1996; Barlic, Andrews et al. 
2000). Arrestins 2 and 3 are cytosolic phosphoproteins that were previously characterized 
for their role in endocytosis of ligand-bound chemokine receptors, particularly CXCR1, 
which is the high affinity receptor for the neutrophil chemotactic factor, IL-8. Arrestins 2 
and 3 act by uncoupling activated G protein-coupled receptors from their associated 
heterotrimeric G proteins, they bind directly to the cytoplasmic tail of the CXCR1 
receptor (Barlic, Andrews et al. 2000; Ferguson, Downey et al. 1996). 
Dominant negative mutants of arrestin 2 and 3 were shown to inhibit the release of 
granules when transfected into rat basophilic leukemia (RBL) cells, a cell line resembling 
mast cells and basophils (Barlic, Andrews et al. 2000). Interestingly, arrestins 2 and 3 
also associate with the primary and secondary granules in IL-8-activated neutrophils, and 
they do so by binding to Hck and Fgr, respectively (Barlic, Andrews et al. 2000). Thus, 
arrestins 2 and 3 act at two sites in the cell during chemokine activation; one at the 
receptor in the plasma membrane and a second on granule membranes. 
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Hypothesis 
The Role of helix VIII of BLT1 in neutrophil responses to LTB4 is well documented 
(Shimizu, Yokomizo et al. 2000; Okuno, Ago et al. 2003; Gaudreau, Beaulieu et al. 
2004). Our lab and others have shown that truncation or mutation in BLT1 can lead to 
abnormal signaling in neutrophils (Baneres, Martin et al. 2003; Gaudreau, Beaulieu et al. 
2004; Okuno, Yokomizo et al. 2005). Gaudreau et al. (Gaudreau, Beaulieu et al. 2004) 
have demonstrated that a mutation in helix VIII leads to significant reduction in BLT1 
internalization. Gaudreault, et al. have shown that receptor endocytosis is crucial for 
LTB4-mediated neutrophil degranulation, whereas Lambert et al. demonstrated that a 
defect in helix VIII of BLT1 leads to multiple pseudopod formation and defective 
chemotaxis. They also proposed that a member of the Rho family of GTPases, RhoA, is 
important for LTB4-mediated chemotaxis. 
Since the intracellular granule movement and granule exocytosis in neutrophils require 
cytoskeleton rearrangement in a similar fashion as in chemotaxis which has been shown 
to be RhoA-dependent and receptor endocytosis is crucial for LTB4'-mediated 
degranulation, we hypothesised that the dileucine motif in helix VIII of BLT1 receptor 
plays a role in RhoA-dependent neutrophil degranulation. 
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Objectives 
To study the role of the dileucine motif and RhoA in neutrophil degranulation. 
• To test the PLB985 cell line stably transfected with BLT1 (wt) or BLT1 (mutant) 
as a model for LTB4 -induced neutrophil degranulation. 
• To determine whether the 2LA mutation in BLT1 effects LTB4-mediated 
degranulation. 
• To determine the signaling pathways involved in wt and mutant BLT1 receptor-
mediated degranulation using pharmacological inhibitors. 
• To determine whether the defective signaling in mutant BLT1 is reversible by co-
expression of constitutively active RhoA. 
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Materials and Methods 
Reagents 
RPMI 1640 and geneticin (G418) were from Invitrogen Canada. FBS, cytochalasin B, Y-
27632 and Triton were from Sigma-Aldrich Canada. DMSO was from Fischer Scientific. 
Dextran and Ficoll-Paque PLUS, were from Amersham Biosciences. U75302,4-amino-
5-(4methylphenyl)-7-(tert-butyl)pyrazolo[3,4-c/] pyrimidine (PP1), iV-benzyl-3,4-
dihydroxylbenzylidenecyanoacetamide (AG490), 4-(4-fluorophenyl)-2-(4-
methylsulfinylphenyl)-5-(4-pyridyl)\H- imidazole (SB203580), 2'-amino-3'-
methoxyflavone (PD98059), , LY294002, and p-nitrophenyl /V-acetyl-P-
glucosaminide,Wortmannin and Pertussis toxin were from BIOMOL. LTB4 was from 
Cayman Chemicals. BSA was from BIO MEDIA Canada. 
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Isolation of human neutrophils 
Neutrophils were obtained from peripheral blood of healthy medication-free volunteers 
after informed consent in accordance with an Internal Review Board-approved protocol, 
as described previously (Stankova, Turcotte et al. 2002). Briefly, peripheral blood 
leukocytes were enriched by dextran sedimentation, layered over a Ficoll-Hypaque 
cushion, and centrifuged at 4000 x g for 20 min. mononuclear leukocytes were collected 
at the interface, whereas neutrophils were obtained from the pellet. The neutrophils 
preparation was depleted of erythrocytes by osmotic shock, then washed and resuspended 
in PBS until used. 
P-Hexosaminidase release assays 
Degranulation was determined by measuring the release of a granule marker, ft-
hexosaminidase, as described previously by Ali et al. (Ali, Richardson et al. 1993), with 
some modifications. For PLB-BLT cells, after 3 days of differentiation, 2.5 x 105 cells 
were washed once with 1 ml of PBS. For human neutrophils, 4 x 106 cells were used. 
When necessary, cells were incubated with inhibitors for indicated times at 37°C. Cell 
pellets were resuspended in 250 |il of PBS containing cytochalasin B (4.8 |ig/ml) and 
incubated for 5 min. Cytochalasin B was used to facilitate degranulation without priming 
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cells with other reagents that might interfere directly in intracellular signaling pathways. 
Cells were then stimulated with LTB4 (100 nM) or other stimuli for 10 min. 
After stimulation, ^-hexosaminidase activity was measured in 50 jul of cell-free 
supernatant by spectrophotometric analysis using 50|xl of 2 mM p-nitrophenyl-jV-acetyl-
P-glucosaminide as chromogenic substrate. Cell supernatant and substrate were incubated 
for 1 h at 37°C. The reaction was stopped by adding 150 |il of a 0.1M Na2C03-NaHC03 
buffer at pH 9.5. OD was then read at 405 nm using a spectrophotometer (BioRad). 
Values were expressed as percentages of total (^-hexosaminidase, which was determined 
in cells lysed with 0.1% Triton X-100. All percentages were corrected by subtracting 
spontaneous (^-hexosaminidase release in cell supernatants. All assays were performed in 
triplicate, and OD was read three times. 
Construction of Myc-tagged wild type and mutant receptors. 
The cloning of WT BLTl-cDNA and generation of the mutant 2L (304-305)A in which 
leucines were substituted with alanines was previously described (Gaudreau, Le Gouill et 
al. 1998; Gaudreau, Beaulieu et al. 2004). All constructions were subcloned into pcDNA3 
expression vector (invitrogen) and sequenced (University of Calgary, Alberta, Canada). 
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Cell culture and transfection 
PLB-985 cells were grown in RPMI 1640 supplemented with 5% FBS and gentamicin 
sulfate (40 |xg/ml). All cells were cultured at 37°C in a humidified 5% CO2 incubator. 
PLB-985 cells were stably transfected with a pcDNA3 vector containing a construct 
encoding for a myc-tagged BLT1 sequence (Gaudreau, Le Gouill et al. 2002) or myc-
tagged BLT1 mutant sequence (Gaudreau, Beaulieu et al. 2004) . In short, 30 x 106 cells 
were electroporated at 320 V using 30 |ig of pcDNA3-BLT. Cells were then cultured for 
3 wk in medium containing G418 at a concentration of 800 ng/ml. After 2 wk of G418 
selection, cells were sorted twice using a FACSVantage cell sorter (BD Biosciences). 
These cells are referred to as PLB-BLT1 (WT) and PLB- BLT1 (2LA). 
Differentiated PLB-BLT1 (wt) cells or PLB-BLT1 (2LA) (10 x 106 cells), loaded in 
nucleofection buffer, were nucleofected with 10 ^g of plasmid containing constitutively 
active RhoA or an empty vector pcDNA3 using nucleofector program U02 (Amaxa 
Biosystems). For degranulation experiments, cells were used 8 h post transfection PLB-
BLT1 (WT) and PLB- BLT1 (2LA) cells were cultured in medium supplemented with 
1.25% DMSO for 3 days before each experiment to induce cell differentiation into a 
neutrophil-like phenotype, unless mentioned otherwise. 
4 0 
Statistical analyses 
Data were analyzed by using PRISM5 software. Paired Student's t test was performed 
where indicated. Differences were considered significant at p S'0.05 for n £3. 
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Results 
The Dileucine motif in helixVIII of the BLT1 receptor plays an important role in 
LTB4 mediated degranulation in neutrophils. 
We and others (Yokomizo, Masuda et al. 2000; Okuno, Ago et al. 2003; Gaudreau, 
Beaulieu et al. 2004; Okuno, Yokomizo et al. 2005) have shown that the distal 2LA (304-
305) motif, which is in helix VIII of BLT1 receptor plays an important role in 
phospholipase C activation, receptor desensitization, internalization and chemotaxis. To 
investigate whether mutation of dileucine motifs of BLT1 affects degranulation, we used 
PLB-985 cells stably transfected with BLTl-wt and the mutant 2LA (304-305). Those 
cells were cultured in medium supplemented with DMSO for 3 days to induce cell 
differentiation into a neutrophil-like phenotype. Differentiated PLB-BLT1 (wt) cells and 
freshly acquired human neutrophils were stimulated with LTB4, its respective vehicle 
ethanol and fMLP as a control. LTB4 mediated degranulation levels in PLB-BLT1 (wt) 
(figlA) and freshly acquired human neutrophils (figIB) were comparable. The 
degranulation levels in PLB-BLT1 (wt) (figlC) and human neutrophils (figID) were 
concentration dependent. Degranulation levels in PLB-BLT1 (2LA) mutant cells were 
60±5% less (fig2B) compared to PLB-BLT1 (wt) cells (fig2A) and human neutrophils 
(fig IB). We also observed that PLB-BLT1 (2LA) did not degranulate in a concentration 
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dependent manner. In contrast to PLB-BLT1 (wt) cells and neutrophils, increasing the 
concentration of LTB4 failed to bring about any change in degranulation levels ofPLB-
BLT1 (2LA) cells (fig 2C). This strongly suggests that the distal dileucine motif in helix 
VIII plays a crucial part in LTB4 mediated downwards signaling in neutrophil 
degranulation. It was interesting to see that there remained a residual LTB4 dependent 35-
40% degranulation in PLB cells transfected with 2LA. 
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Fig 1: PLBB-BLT1 (WT) and Neutrophil degranulation. 
A) PLB-P85 cells stably transfected with BLT 1 (WT) differentiated for 0-3 days using 
DMSO. (2.5 X 105) and, B) freshly isolated human neutrophils (3 X 10"6) were 
stimulated with 10"7M of LTB4 or its appropriate vehicle (EtOH) or 10"7M fMLP 
(positive control) for 10 min. After stimulation, p-hexosaminidase release was 
assessed. C) PLB-P85 cells stably transfected with BLT1 (WT) and D) Freshly 
isolated human neutrophils (3 X106) were stimulated with of LTB4 (10~5- 10"9M) or 
its appropriate vehicle (ethanol EtOH) or 10"7M fMLP (positive control) for 10 min. 
After stimulation, p-hexosaminidase release was assessed 
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FIG 2: PLB BLT1 (2LA) and PLB BLT1 (WT) degranulation 
A) PLB-P85 cells stably transfected with BLT1 (WT) and, B) PLB-985 cells stably 
transfected with BLT 1 (2LA) (2.5 X 105) were differentiated for 0-3 days using 
DMSO and were stimulated with 10"7M of LTB4 or it appropriate vehicle (EtOH) or 
10"7M fMLP (positive control) for 10 min. After stimulation, P-hexosaminidase 
release was assessed. C) PLB-P85 cells stably transfected with BLT1 (2LA) were 
differentiated for 0-3 days using DMSO (2.5 X 105) were stimulated with (10~5- 10" 
9M) of LTB4 or its appropriate vehicle (EtOH) or 10"7M fMLP (positive control) for 
10 min. After stimulation, P-hexosaminidase release was assessed. 
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A Pertussis -sensitive Gai protein subunit, PI3k and Src family kinases are involved 
in LTB4 mediated neutrophil degranulation. 
Signaling of BLT1 through Gai protein subunit and its involvement in neutrophils 
degranulation has been shown previously (Masuda, Itoh et al. 2003; Gaudreault, 
Thompson et al. 2005). In order to assess whether the residual degranulation in PLB-
BLT1 (2LA) cells was also dependent on Gai protein subunit signaling, we used pertussis 
toxin, an inhibitor of Gai and GaO signaling. 
PLB-BLT1 (wt), PLB-BLT1 (2LA) and human neutrophils cell were pretreated with PTX 
(50nM) for 6 h, followed by 10 min stimulation with LTB4 (100nM). Pretreatment with 
PTX resulted in 80 % reduction in degranulation levels of PLB-BLT1 (wt) (fig3A) and 
40% reduction in degranulation levels of neutrophils (fig3C), while PTX pretreatment did 
not have any significant effect on PLB-BLT1 (2LA) residual degranulation (fig 3B). 
Previously it has been shown that BLT-1 mediated degranulation in RBL-2H3 cells (Ito, 
Yokomizo et al. 2002) and PLB985 cells (Gaudreault, Thompson et al. 2005) stably 
transfected with BLT1 cDNA was partially dependent on PI3k. To see if the residual 
degranulation in PLB-BLT1 (2LA) cells was dependent on PI3K activation, we used the 
specific PI3k inhibitor wortmanin (lfiM). 
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Pre-incubation for lh with wortmanin followed by stimulation with LTB4 led to 60% 
inhibition of degranulation of PLB-BLT1 (wt) (fig4A) and 60% inhibition of human 
neutrophils (fig4C) degranulation. Incubation with wortmanin did not produce any 
reduction in degranulation levels in PLB-BLT1 (2LA) cells (fig4B). 
Gai protein subunit activation is known to play an important role in activation of several 
kinases including src kinase by different GPCR. Src family kinases are also known to be 
involved in certain neutrophil functions including granule secretion (Gaudreault, 
Thompson et al. 2005). To assess whether the residual degranulation in PLB-BLT1 
(2LA) is dependent on scr kinase activation, PLB-BLTlwt and PLB-BLT12LA cells 
were pre-incubated or not with src kinase inhibitor PP1 (10|iM) for lh and then 
stimulated with LTB4. PLB-BLT1 (wt) (fig5A) cells showed 40% reduction of 
degranulation levels compared to non pre-incubated cells, whereas PLB-BLT1 (2LA) 
(fig5B) cells did not show a significant reduction in degranulation levels. Human 
neutrophils pre-incubated with the inhibitor ppl (30 |xM) for lh showed 45% reduction of 
degranulation levels after stimulation with LTB4 (fig5C). Moreover PPI inhibition of 
PLB-BLT1 (wt) was concentration dependent, reaching 65% at the inhibitor 
concentration of 50(xM (fig5D). There was no effect of increased concentration on PLB-
BLT1 (2LA) mutant cells. The degranulation rate remained at similar level from 0-50(iM 
(fig5E). 
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These results indicate that the residual degranulation by 2LA mutant BLT1 is not the 
result of downstream signaling of Gaj/o, PI3K, or src kinase activation. 
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Fig 3: Effects of Got; protein subunit blockade on LTB4-mediated degranulation. 
A) PLB-BLT1 (WT) cells, B) PLB-BLT1 (2LA) and C) Human neutrophils were 
pretreated or not with Bordetella pertussis toxin (50 ng/ml) at 37°C for 6 h. After 
incubation with PTX, cells were stimulated with 100 nM LTB4 or its appropriate vehicle 
(ethanol; EtOH) or fMLP for 10 min. After stimulation, ^-hexosaminidase release was 
assessed. 
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Fig 4. Effects of PI3K inhibition on LTB4-mediated degranulation. 
A) PLB-BLT1 (WT) cells, B) PLB-BLT1 (2LA) and C) human neutrophils were 
pretreated or not with wortmannin (1 |j.M) at 37°C for 1 h. After incubation with 
the inhibitor, cells were stimulated with 100 nM of LTB4, its appropriate vehicle 
(ethanol) or fMLP for 10 min. After stimulation, ^-hexosaminidase release was 
assessed. 
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Fig5: Effects of inhibition of the Src family of the kinase on LTB4-mediated 
degranulation in PLB-BLT cells and human neutrophils. 
A) PLB-BLT 1 (wt) cells (2.5 x 105) and B) PLB-BLT 1 (2LA) cells (2.5 x 105) were 
pretreated or not with Src family kinases inhibitor PP1 (10 |xM) for 1 h at 37°C and were 
then stimulated with LTB4 (100 nM) or its vehicle (ethanol; EtOH) or fMLP for 10 min. 
After stimulation, P - h e x o s a m i n i d a s e release was assessed. C) Human neutrophils (3 x 106 
cells), isolated from peripheral blood were pretreated or not with PP1 (30 |iM) for lh at 
37°C and were then stimulated with LTB4 (100 nM) or its vehicle (ethanol) or fMLP for 
10 min. After stimulation, P - h e x o s a m i n i d a s e release was assessed. D) Concentration-
dependent inhibition of PLB-BLT 1 (wt) degranulation using PP1 (0-50 |xM). E) 
Concentration-dependent inhibition of PLB-BLT1 (2LA) degranulation using PP1 (0-50 
HM). 
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***= P <ooooi 
**=P<0 0009 
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JAK2, P38 kinase and MEK/ERK kinases do not play a role in BLT1 mediated 
degranulation. 
Leukotrienes have been shown to activate JAK/STAT pathways (Lukashova, Chen et al. 
2003) as well as MAPK signaling pathways (Mocsai, Jakus et al. 2000; Petrin, Turcotte 
et al. 2006). 
To determine whether residual LTB4-dependent degranulation in PLB-BLT1 (2LA) cells 
was mediated by JAK/STAT or MAPK signaling pathways we used specific inhibitors 
for JAK2, P38 kinase, JNK and MEK/ERK kinases. 
Human neutrophils, PLB-BLT1 (wt) and PLB-BLT1 (2LA) were pre-incubated with 
P38kinase inhibitor SB203580 (10|iM) for lh. Our results indicated that in human 
neutrophils there was a statistically significant reduction of degranulation levels (35%) 
(fig6C). PLB-BLT1 (wt) (fig6A) and PLB-BLT1 (2LA) (fig6B) did not show significant 
reduction in degranulation levels. 
PLB-BLT1 (wt), PLB-BLT (2LA) and human neutrophils were pre-treated with 
MEK/ERK kinase inhibitor PD980059 (IOjiM) (fig7.A-C) or JNK inhibitor (SP600125) 
(fig8.A-C) or JAK2 inhibitor, AG490 (lO^M) (fig9.A-C) for lh. No statistically 
significant reduction in degranulation was observed compared to PLB-BLT1 (wt), PLB-
BLT 1 (2LA) and human neutrophils stimulated with LTB4 alone. 
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FIG 6: Effects of, p38 inhibition on LTB4-mediated degranulation of PLB-BLT 1 (wt), 
PLB-BLT 1 (2LA) cells and human neutrophils 
A) PLB-BLT (WT) cells (2.5 x 105 cells), B) PLB-BLT (2LA) cells (2.5 x 105 cells) 
and C) human neutrophils were pre-treated or not with p38 kinase inhibitor 
(SB203580), 10 or 30 |iM) for 1 h at 37°C followed by stimulation with LTB4 
(100 nM), its vehicle (ethanol; EtOH) or fMLP for 10 min After stimulation, P-
hexosaminidase release was assessed. 
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FIG 7: Effects of MEK/ERK inhibition on LTB4-mediated degranulation of PLB-BLT 1 
(wt), PLB-BLT 1 (2LA) cells and human neutrophils 
A) PLB-BLT (WT) cells (2.5 x 105 cells), B) PLB-BLT (2LA) cells (2.5 x 105 cells) and 
C) human neutrophils were pre-treated or not with MEK/ERK1/2 kinase inhibitor 
(PD98059 (PD), 10 ^ M) for 1 h at 37°C followed by stimulation with LTB4 (100 
nM), its vehicle (ethanol; EtOH) or fMLP for 10 min After stimulation, P-
hexosaminidase release was assessed. 
n= 3 
*=P<0.05 
5 5 
BLT1 WT 
without JNK 
Inhib 
with JNK 
Inhib 
B 
BLT1 2LA 
without JNK 
Inhib 
with JNK 
Inhib 
c 
Neutrophils 
20t 
without JNK with JNK 
Inhib Inhib 
FIG 8: Effects of JNK kinase inhibition on LTB4-mediated degranulation of PLB-BLT1 
(wt), PLB-BLT 1 (2LA) cells and human neutrophils 
A) PLB-BLT (WT) cells (2.5 x 105 cells), B) PLB-BLT (2LA) cells (2.5 x 105 cells) and 
C) human neutrophils were pre-treated or not with a JNK inhibitor SP600125 for 1 h 
at 37°C followed by stimulation with LTB4 (100 nM), its vehicle (ethanol; EtOH) or 
fMLP for 10 min After stimulation, P-hexosaminidase release was assessed. 
n= 3 
*=P<0.05 
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FIG 9: Effects of Jak kinase inhibition on LTB4-mediated degranulation of PLB-BLT1 
(wt), PLB-BLT 1 (2LA) cells and human neutrophils 
A) PLB-BLT (WT) cells (2.5 x 105 cells), B) PLB-BLT (2LA) cells (2.5 x l.O5 cells) and 
C) human neutrophils were pre-treated or not with a Jak kinase inhibitor (AG490 (AG), 
10 |iM) for 1 h at 37°C followed by stimulation with LTB4 (100 nM), its vehicle (ethanol; 
EtOH) or fMLP for 10 min After stimulation, P - h e x o s a m i n i d a s e release was assessed. 
n= 3 
*=P<0.05 
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RhoA activation is crucial for LTB4 mediated degranulation in neutrophils. 
LTB4 signals through BLT1 and BLT2. Since several inhibitors known to inhibit 
degranulation through BLT1 failed to reduce the residual degranulation levels in the 
mutant BLT1-2LA cells. It was important to rule out the endogenous BLT2 expression 
and its influence on degranulation in mutant BLT1-2LA cells. PLB-BLT1 (wt) and PLB-
BLT1 (2LA) cells were pre-treated with BLT1 antagonist U75302 (10 |iM) and BLT2 
antagonist LY2552833 (10 nM) for 30min and then stimulated with LTB4 for 10 min. 
We observed that degranulation was completely abrogated in both PLB-BLT 1 (wt) (fig 
10C) and PLB-BLT 1 (2LA) (figlOD) with BLT1 antagonist, whereas BLT2 antagonist 
had no effect on BLT1 (wt) or on PLB-BLT 1 (2LA) (figlOA-B). 
RhoA and Racl activation by GPCRs has been shown to play an important role in 
neutrophil chemotaxis, since both granule mobilization and chemotaxis involve 
cytoskeleton re-arrangement. It was interesting to see the effect of the RhoA and Racl 
activation inhibition on LTB4-mediated degranulation. 
PLB-BLT 1 (wt) and PLB-BLT 1 (2LA) were pre-incubated with Racl inhibitor 
NSC23766 lOO^M for lh (fig 11 A-B). No statistically significant reduction in 
degranulation was observed compared to PLB-BLT 1 (wt) and PLB-BLT 1 (2LA) 
stimulated with LTB4 alone. 
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However when Human neutrophils, PLB-BLT1 (wt) and PLB-BLT 1 (2LA) were pre-
incubated with PI6OROCK inhibitor Y-27632 (10|iM) for lh. A 50±5% reduction of p-
hexosaminidase release in human neutrophils (figl2 C) and 70±5% reduction of P-
hexosaminidase release in PLB-BLT1 (wt) cells was observed (fig9A). Whereas, Y-
27632 inhibitor did not inhibit P-hexosaminidase release in PLB-BLT1 (2LA) mutant (fig 
12 B). It was also observed that inhibition of P-hexosaminidase release by PI6OROCK 
inhibitor, in PLB-BLT 1 (wt) cells (fig 12 D) was concentration dependent, reaching its 
maximum inhibition at IOjiM. Increase in the concentration of PI 60 ROCK inhibitor did 
not have an effect on PLB-BLT 1(2LA) (fig 12 E). 
To assess the extent of RhoA involvement in LTB4-mediated degranulation, we 
performed a degranulation assay on PLB-BLT 1 (wt) and PLB-BLT 1 (2LA) cells that 
were transiently transfected with constitutively active RhoA or an empty vector 
(pcDNA3). Degranulation levels in PLB-BLTl(wt) cells (figl3 A) were similar to cells 
transfected with empty vector or those with constitutively active RhoA, whereas there 
was a 65±5% increase in degranulation levels of PLB-BLT 1 (2LA) cells (fig 13 B) 
transfected with constitutively active RhoA compared to PLB-BLT1(2LA) cells 
transfected with an empty vector. 
Since the reduction in degranulation associated with the mutation of dileucine (304-305) 
motif in helix VIII can be corrected by transfecting cells with constitutively active RhoA, 
it appears plausible that the 2LA mutation caused the BLT1 to lose its capacity to activate 
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the Rho pathway. These results also provided a first indication that the Rho pathway may 
play a role in neutrophil degranulation. 
Ongoing studies are concentrated on directly assessing whether BLT1 can activate RhoA 
and whether BLT1-2LA is deficient in this function. 
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Fig 10: Effect of BLT1 and BLT2 antagonist on LTB4-induced degranulation. 
PLB-BLT 1 (WT and 2LA) cells (2.5 x 105 cells) were differentiated with DMSO from 0 
to 3 days. Differentiated A) PLB-BLT (WT) cells and B) PLB-BLT(2LA) (2.5 x 105 
cells) were pretreated or not with BLT2 antagonist LY2552833 (10 ^M) at 37°C or C-D) 
BLT1 antagonist U75302 (10 fiM) for 30 min before stimulation for 10 min with 100 nM 
LTB4 or its appropriate vehicle (EtOH) or fMLP. After stimulation, P-hexosaminidase 
release was assessed. 
n= 3 
Fig C: ***=P<0.0001, fig D: ***=P<0.0010 
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Fig 11: Effects of Racl inhibition on LTB4-mediated degranulation in PLB-BLT1 (WT or 
2LA) 
PLB-BLT 1 (WT or 2LA) cells (2.5 x 105 cells) differentiated with DMSO from 0 to 3 
days. Differentiated A) PLB-BLT (WT) cells and B) PLB-BLT(2LA) (2.5 x 105 cells) 
were pretreated or not with Racl inhib.NSC23766 lOOfiM at 37°C for 1 hour before 
stimulation for 10 min with 100 nM LTB4 or its appropriate vehicle (EtOH) or fMLP. 
After stimulation, P - h e x o s a m i n i d a s e release was assessed. 
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Fig 12: Effects of ROCK (P160 ROCK) inhibition on LTB4-mediated degranulation in 
PLB-BLT 1 (WT or 2LA) cells and human neutrophils. 
PLB-BLT 1 (WT or 2LA) cells (2.5 x 105 cells) were differentiated with DMSO from 0 to 
3 days. Differentiated A) PLB-BLT (WT) cells and B) PLB-BLT (2LA) (2.5 x 105 cells) 
and (C) human neutrophils (3 x 106 cells) were pre-treated or not with Y62375 inhibitor 
(10 |iM) at 37°C for 1 hour before stimulation for 10 min with 100 nM LTB4 or its 
appropriate vehicle (EtOH) or fMLP. After stimulation, ^-hexosaminidase release was 
assessed. D) Concentration-dependent inhibition of PLB-BLT 1 (wt) degranulation using 
Y62375 inhibitor (0-10 nM). E) Concentration-dependent inhibition of PLB-BLT1 
(2LA) degranulation using Y62375 inhibitor (0-10 ^M). 
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Fig 13: Transfection of PLB-BLT1 (wt) and (2LA) mutant with constitutively active 
RhoA. 
A) Differentiated PLB-BLT 1 (WT) and B) PLB-BLT 1 (2LA) cells were transfected 
with 10(iM of constitutively active RhoA plasmid or an empty vector (pc DNA) 
and stimulated with 100 nM LTB4 or its appropriate vehicle (EtOH) or fMLP. 
After stimulation, P - h e x o s a m i n i d a s e release was assessed. 
n= 3 
***=p<0 0007 
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Discussion 
In our study, we addressed the role of the helix VIII of BLT1 receptor in neutrophil 
degranulation and the intracellular signaling that follows the stimulation of BLT1 by 
LTB4. 
The following conclusions can be drawn from our study: (1) the neutrophil-like cellular 
model of PLB-BLT1 and PLB-BLT1 mutants is suitable for studying the effects of 
mutations on BLT1-mediated degranulation. (Smith, Borgeat et al.). (2) The distal 
dileucine motif in helix VIII of the BLT1 receptor plays an important role in LTB4-
mediated degranulation in neutrophils. (3) Pertussis toxin-sensitive Gai/o protein subunit 
and PI3k and Src family kinases are involved in LTB4-mediated neutrophil degranulation. 
(4) JAK2, p38 kinase and MEK/ERK kinases do not play a role in BLT1-mediated 
degranulation. (5) RhoA downstream signalization may be disrupted by the mutation of 
the distal dileucine motif leading to a considerable reduction in degranulation. The 
degranulation levels in mutant BLT1 cells were restored to the levels of human 
neutrophils and PLB-BLT 1 (wt) degranulation, after the mutant PLB-BLT 1 (2LA) cells 
were transfected with a constitutively active form of RhoA. 
The promyeloid PLB-985 cell line has been shown to differentiate into neutrophil or 
monocyte-like cells (Tucker, Lilly et al. 1987). Pedruzziet al. (Pedruzzi, Fay et al. 2002) 
used differentiated PLB-985 cells to study fMLP-mediated degranulation. PLB-985 cells 
were also used byKaldi et al. (Kaldi, Kalocsai et al. 2003) to show that fMLP-mediated 
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degranulation was dependent on the presence of cholesterol in the cell membrane. 
Gaudreault et al. (Gaudreault, Thompson et al. 2005) studied the involvement of BLT1 
endocytosis and Yes kinase activation in degranulation using PLB-985 cells. Similarly 
Lambert et al. used PLB985 cells to study the role of the distal dileucine motif of helix 
VIII and RhoA in LTB4-mediated chemotaxis. Christophe Pivot-Pajot et al. (Pivot-Pajot, 
Chouinard et al. 2009) recently characterized degranulation and phagocytic capacity of 
PLB-985 cells. 
Even though PLB-985 cell are shown to be a suitable model for neutrophils, an important 
step of our study was to compare the degranulation levels of stably transfected 
differentiated PLB-BLT 1 (wt) cells with freshly acquired human neutrophils which can 
be later used as a standard of comparison with mutant PLB-BLT 1 cells. Our results 
demonstrated that the degranulation levels of PLB-BLT1 (wt) cells were comparable to 
those of human neutrophils. 
Okuno et al. (Okuno, Ago et al. 2003) demonstrated that BLT1 mutants with a truncated 
or substituted helix VIII showed much higher LTB4 binding than wild-type (WT) receptor 
in HEK293 and CHO cells, despite having comparable expression on the cell surface. In 
addition Gaudreau et al. (Gaudreau, Le Gouill et al. 2002) proposed that Thr-308 is 
involved in GRK6-mediated desensitization of BLT1 signaling in which a C-tail-
truncated BLT1 (G291stop) demonstrating an increased number of binding sites for LTB4 
as well as enhanced signal transduction in response to LTB4 stimulation, whereas 
internalization was drastically reduced when compared with BLT1 (wt). 
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Gaudreau et al. (Gaudreau, Beaulieu et al. 2004) used mutational analysis of determinants 
Located in the C-terminal (C) tail of BLT1 and found that disruption of the distal 
dileucine (Leu304-Leu305) motif resulted in a mutant BLT1 with a higher number of 
binding sites on the cell surface, whereas the 2LA mutant BLT1 showed only a slight 
increase in the number of binding sites. Substitution of Leu304-Leu305 appeared to prevent 
LTB4-induced BLT1 internalization. Similarly Lambert et al. proposed that mutation of 
distal dileucine (Leu304-Leu305) of BLT1 disrupts the signalization of RhoA and leads to 
formation of multiple pseudopods, thus affecting chemotaxis whereas the addition of 
constitutively active RhoA corrected the defect. 
Receptor internalization is an important part of downstream signaling, whereas 
cytoskeletal rearrangement plays a crucial role in granule movement in the process of 
degranulation. Our results demonstrated that substitution of dileucine motif with alanine 
in 2LA mutant lead to a reduction of 60-65% of degranulation levels compared to PLB-
BLT 1 (wt) and human neutrophils, suggesting that the distal dileucine motif plays an 
important role in BLT1 mediated neutrophil degranulation. 
The reduction but not total abrogation of degranulation in PLB-BLT1 (2LA) mutant cells 
provided us with dual challenge 1) to determine the extent of the involvement of the 
dileucine motif in the process of degranulation and 2) to see if there is an alternative 
pathway involved which may be independent of the dileucine motif. 
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Signaling of BLT1 through Gai/o protein subunit and its involvement in neutrophil 
degranulation has been shown before, Masuda et al. (Masuda, Itoh et al. 2003) using a 
reconstitution system made up of GPCR and heterotrimeric G proteins on extracellular 
baculovirus particles (budded virus (BV) showed that Ga, couples to BLT1. In addition 
Gaudreau et al. used Cos-7 cells to demonstrate that signaling through the leukotriene B4 
receptor involves GaL Whereas Gaudreault et al. demonstrated that degranulation levels 
in differentiated PLB985 cells stably transfected with BLT1 were significantly reduced 
once treated with Ga^0 inhibitor PTX. Several studies have also demonstrated the 
relevance of PI3k in LTB4 mediated degranulation. 
Ito et al. (Ito, Yokomizo et al. 2002) using BLT1 rat basophilic leukemia cells (RBL-
2H3) showed that PI3k was necessary for enzyme release. Similarly Gaudreau et al. 
demonstrated the importance of PI3k in degranulation using differentiated PLB-BLT 1 
cells. 
All of these findings made Ga^0 and PI3k good candidates for testing the role of the distal 
dileucine motif (L304-L305) in the helix VIII of BLT1 receptor. The Gai/0 inhibitor PTX 
significantly reduced the degranulation levels in both PLB-BLT1 (wt) and human 
neutrophils, as had been shown before by Gaudreault et al, but it did not have any effect 
on residual degranulation levels of PLB-BLT1 (2LA) mutant with disrupted dileucine 
motif, indicating that intact distal dileucine motif (304-305) in helix VIII is essential for 
BLT1 to signal through Gai/0. 
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Our studies also demonstrated that PI3K is important for LTB4 mediated degranulation in 
PLB-BLT1 (wt) and human neutrophils but the PI3K inhibitor did not have any effect on 
degranulation levels of PLB-BLT 1 (2LA) mutant cells. Thus reiterating the fact that an 
intact dileucine motif in helix VIII is important for signaling through PI3K. 
Src family kinases have already been connected to different cellular activities in human 
neutrophils, such as degranulation. Mocsai et al. (Mocsai, Ligeti et al. 1999) 
demonstrated that adhesion-dependent neutrophil lactoferrin release requires Fgr and Hck 
activity by using src kinase blockade with PP1 and neutrophils deficient in Fgr and Hck. 
Similarly Gaudreault et al. (Gaudreault, Thompson et al. 2005) has shown the 
involvement of src kinase in LTB4-mediated degranulation using PLB-BLT1 cells. 
As expected our results also indicated significant reduction in degranulation levels of 
PLB-BLT 1 (wt) cells but Src inhibitor did not have any effect on degranulation levels of 
PLB-BLT 1 (2LA) mutant cells. Our results confirmed the involvement of Src family 
( 
kinase 
Since several inhibitors known to inhibit degranulation failed to reduce the residual 
degranulation levels in PLB-BLT I (2LA) mutants it was important to rule out the 
involvement of BLT2 receptor. Using BLTl and BLT2 antagonists we confirmed that the 
residual degranulation was indeed due to signaling through BLTl receptor. 
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The BLT2 antagonist had no effect on PLB-BLT 1 (wt) or PLB-BLT 1 (2LA) mutant cells 
degranulation levels whereas BLT1 antagonist completely abrogated degranulation in 
both the wt and 2LA mutant cells. 
Receptor endocytosis is an important step for BLT1 signaling and degranulation 
(Gaudreault, Thompson et al. 2005), knowledge of the fact that disruption of the 
dileucine motif significantly reduces receptor internalization (Gaudreau, Beaulieu et al. 
2004) suggested that there may be an alternate path way involved which is independent 
of internalization and does not signal through conventional pathway. 
The prospect of an alternate pathway led us to venture in direction not previously 
explored in degranulation. MAPK family is known to regulate several important 
neutrophil functions. In addition Downey et al (Downey, Butler et al. 1998) proposed that 
exposure of neutrophils to inflammatory stimuli such as the chemoattractant fMLP leads 
to activation of MEK. Wozniok et al.(Wozniok, Hornbach et al. 2008) showed that 
Inhibition of the ERK signaling pathway abolishes neutrophil migration induced by C. 
albicans filaments selectively impairing its ability to kill. However our results suggest 
that MEK/ERK inhibitor did not produce a significant reduction in degranulation levels 
of PLB-BLT 1 (wt) or PLB-BLT 1 (2LA) mutant cells removing it from our list of 
suspects responsible for PLB-BLT 1 (2LA) mutant's residual degranulation. Similarly our 
results excluded JNK and P38 the other two members of MAPK family from the list of 
perpetrators. 
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Several GPCRs are capable of signaling without internalization. Frank et al. (Frank, Saito 
et al. 2002) proposed that Angiotensin II receptor can activate JAK2. In addition 
Lukashova et al. (Lukashova, Chen et al. 2003) demonstrated that PAFR is capable of 
signaling through JAK2 without internalization and Gaudreau et al. (Gaudreau, Beaulieu 
et al. 2004) has shown that receptor internalization in PLB-BLTl (2LA) mutant cells was 
significantly reduced. To see if PLB-BLT 1 (2LA) mutant cells were signaling in similar 
fashion as Angiotensin II receptor or PAFR and if the JAK/STAT was at play here, we 
used JAK2 inhibitor AG490. Our result excluded the involvement of JAK2. 
The major function of Rho GTPases is to regulate the assembly and organization of the 
actin cytoskeleton (Hall 1998). Some common target proteins appear to be utilized by 
both Rac and Cdc42 in the induction of lamellipodia and filopodia respectively (Manser, 
Leung et al. 1994; Manser, Chong et al. 1995; Bagrodia, Taylor et al. 1995), however our 
results indicated that both Racl and cdc42 (results not shown) were not involved in the 
signaling of residual degranulation of PLB-BLT 1 (2LA) mutant cells. 
ROK pi60 (also known as Rho-associated coiled-coil-containing protein kinase or 
ROCK) appears to be required for Rho-induced assembly of stress fibres and focal 
adhesions (Ishizaki, Maekawa et al. 1996; Ishizaki, Naito et al. 1997). Expression of the 
constitutively active catalytic domain of ROKa induced stellate actin-myosin filaments in 
HeLa and Swiss3T3 cells (Leung, Chen et al. 1996; Ishizaki, Naito et al. 1997). 
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Inhibition of ROK, on the other hand, using a pharmacological inhibitor (Y-27632) 
caused loss of serum and [Val14] Rho-induced stress fibres (Uehata, Ishizaki et al. 1997). 
Lambert et al. has shown that pretreatment of differentiated PLB-BLT 1 cells with pi60 
Rock (Y-27632) formed multiple pseudopod indicating defective chemotaxis. In our 
study we pretreated or not differentiated PLB-BLT1 (wt) and PLB-BLT 1 (2LA) mutant 
cells with pi 60 Rock (Y-27632) inhibitor. Our results indicated involvement of the RhoA 
in degranulation process as pretreatment with the inhibitor caused 70% reduction 
degranulation levels PLB-BLT 1 (wt) cells but the inhibitor did effect the residual 
degranulation levels of PLB-BLT 1 (2LA) mutant cells. 
To further investigate the effect of the defect in the dileucine motif, we transfected 
differentiated PLB-BLT 1 (wt) and PLB-BLT 1 (2LA) cells with constitutively active 
RhoA. Interestingly enough the degranulation levels in PLB-BLT1 (2LA) mutant cells 
were restored to PLB-BLT 1 (wt) levels. The transfection had no effect on PLB-BLT 1 
(wt) degranulation levels suggesting that RhoA activation is crucial for degranulation 
process and the dileucine motif in helix VIII is essential for activation of RhoA and 
downstream signaling. 
7 3 
2LA degranulation restored to WT 
degranulation levels 
Diagram 1: suspected pathway of degranulation in A: WT, B: 2LA and G: 2LA 
transiently transfected with constitutively active RohA. 
74 
Our study has implicated src family kinases, PI3K and RhoA in LTB4-mediated 
degranulation; the sequence in which these components are activated is still unclear. 
Further studies are also required to confirm binding of RhoA to the dileucine motif in 
helix VIII, since it remains to be seen if Rho A/ROCK is activated by helix VIII or by an 
alternative mechanism. 
Insight into mechanisms regulating degranulation of neutrophils could enable us to 
specifically modify granule recruitment and exocytosis of neutrophils at the site of 
infection. This could lead to novel therapeutic strategies for counteracting neutrophil-
induced tissue damage, for example, in sepsis, asthma, ischemia/reperfusion injury and 
transplant rejection 
7 5 
Conclusion 
Neutrophil degranulation is an important part of immune system. Lack of or defect in 
neutrophil degranulation can have serious consequences. Our results suggest that RhoA 
activation is crucial for neutrophil degranulation and the distal dileucine motif (304-305) 
plays an important role in RhoA activation. In addition the residual degranulation 
suggests that there may be other pathways involved in LTB4-mediated degranulation 
which are independent of RhoA activation and receptor internalization. 
Similarly our results indicate that Got;/,, Protein subunit, PI3K and src family kinases play 
a role in degranulation signaling. However the results suggest that they are activated 
downstream of RhoA. In addition our results also demonstrate that JAK2, p38, 
MEK/ERK and JNK do not play a role in LTB4-mediated degranulation. 
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